Insiders / Albers Jeffrey W.
Albers Jeffrey W.
CIK 1638474personinsider
Companies
4
First seen
Mar 3, 2021
Last activity
Aug 10, 2026
Holdings
4 companies · 4 positionsView all →
| Company / security | Shares held | Latest |
|---|---|---|
| Aeglea BioTherapeutics, Inc. · AGLE | 9,360 | — |
| Common stock | 9,360 | Aug 7, 2026 |
| Options | 45,000 | Aug 7, 2026 |
| Magenta Therapeutics, Inc. · DNTH | — | — |
| Options | 20,000 | Jun 28, 2022 |
| Kymera Therapeutics, Inc. · KYMR | 0 | — |
| Options | 6,068 | Jun 24, 2026 |
| Blueprint Medicines Corp · BPMC | 0 | — |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Nov 15, 2021 | Sell Open-market sale | BPMC Blueprint Medicines Corp Common Stock | $2.51M | -22K -10.03% | 196,542 | medium |
| May 12, 2021 | Sell Open-market sale | BPMC Blueprint Medicines Corp Common Stock | $1.52M | -16K -8.54% | 175,401 | medium |
| Aug 19, 2021 | Sell Open-market sale | BPMC Blueprint Medicines Corp Common Stock | $1.38M |